The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2019

Filed:

Sep. 02, 2016
Applicants:

Kyungpook National University Industry-academic Cooperation Foundation, Daegu, KR;

Korea Institute of Science and Technology, Seoul, KR;

Inventors:

Jong-Sup Bae, Daegu, KR;

In-San Kim, Daegu, KR;

Won Hwa Lee, Changwon-si, KR;

Jun Young Seo, Daegu, KR;

So Youn Kim, Daegu, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); C07K 14/54 (2006.01); C07K 14/79 (2006.01); C07K 19/00 (2006.01); A61K 47/64 (2017.01); A61P 29/00 (2006.01); C12N 15/62 (2006.01); A61K 38/20 (2006.01); A61K 38/40 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 38/16 (2013.01); A61K 38/17 (2013.01); A61K 47/644 (2017.08); A61P 29/00 (2018.01); C07K 14/54 (2013.01); C07K 14/5406 (2013.01); C07K 14/5431 (2013.01); C07K 14/5437 (2013.01); C07K 14/79 (2013.01); C07K 19/00 (2013.01); C12N 15/62 (2013.01); A61K 38/2006 (2013.01); A61K 38/2026 (2013.01); A61K 38/2073 (2013.01); A61K 38/2086 (2013.01); A61K 38/40 (2013.01); Y02A 50/40 (2018.01);
Abstract

The present invention relates to: a fusion polypeptide in which an anti-inflammatory polypeptide and a ferritin monomer fragment are bound; and a pharmaceutical composition for treating inflammatory diseases, containing the same as an active ingredient and, more specifically, to: a fusion polypeptide in which an anti-inflammatory polypeptide is fused to an N-terminus and/or a C-terminus of a ferritin monomer fragment from which a portion of a fourth loop and a fifth helix, of a human derived ferritin monomer, are removed; and a use thereof for treating inflammatory diseases. As in the above, the fusion polypeptide, which has an amino acid sequence represented by SEQ ID NO: 1 and in which an anti-inflammatory polypeptide is fused to an N-terminus and/or a C-terminus of a fragment of a human-derived ferritin monomer, can fuse two types of anti-inflammatory polypeptides, acting through different mechanisms, into a nano cage and administer the same, and thus the fusion polypeptide can exhibit an excellent effect in the treatment of inflammatory diseases including sepsis.


Find Patent Forward Citations

Loading…